Seasonal Affective Disorder Therapeutics Market Share

Market Share of Seasonal Affective Disorder Therapeutics Industry

The seasonal affective disorder therapeutics market is moderately competitive and consists of a few major players. The factors owing to the competition include the rising launch of anti-depressant drugs, rising approvals of drugs for SAD, and increased R&D activities for the development of novel drugs for depression. Some of the companies operating in the market include AbbVie Inc., Viatris Inc. (Mylan N.V.), Pfizer Inc., Eli Lilly and Company, GlaxoSmithKline plc., Novartis AG, Teva Pharmaceuticals USA, Inc., AbbVie Inc, Sanofi AG, Johnson & Johnson (Janssen Pharmaceuticals, Inc), among others

Seasonal Affective Disorder Therapeutics Market Leaders

1. AbbVie Inc.

2. Eli Lilly and Company

3. Teva Pharmaceuticals USA, Inc.

4. Pfizer Inc.

5. GlaxoSmithKline plc.

*Disclaimer: Major Players sorted in no particular order